ArchiMed is a specialist French private equity firm focused on buyouts of and growth capital investments in European healthcare-oriented companies. The Firm looks to invest €5 to €30 million per transaction and specifically targets companies in the public health, care and wellness, biotech, and medical technology segments of the healthcare industry. ArchiMed was formed in 2014 and is headquartered in Lyon.

M&A Summary

Buy vs Sell

Top M&A Advisors

Join Mergr to view the latest updates and news from ArchiMed.

In the last 3 years, ArchiMed has acquired 4 companies.

ArchiMed’s most common sectors for investment are healthcare services (34%) and life science (23%). The Firm’s most common investment types include buyout (lbo, mbo, mbi) (67%) and secondary buyout (23%). In total, ArchiMed has invested in 1 US state and 5 different countries. Its largest (disclosed) acquisition occurred in 2014 when it acquired MediStreams for $14M.

Join Mergr to view ArchiMed’s full profile and discover more middle-market private equity firms just like it.

What's Mergr?

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
  • 3.5K Private Equity Firms
  • 124K M&A Transactions
  • 133K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 2.9K M&A Advisors
    (Investment Banks and Law Firms)
  • 35K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.